These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 15760076)

  • 21. [Studies on pulsatile release tablets of diltiazem hydrochloride in explosion way].
    Fan TY; Wei SL; Yan WW; Ding WX
    Yao Xue Xue Bao; 2002 Mar; 37(3):221-5. PubMed ID: 12579768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of a matrix tablet prepared with polyacrylamide-g-sodium alginate co-polymers and their partially hydrolyzed co-polymers for sustained release of diltiazem hydrochloride.
    Mandal S; Ray R; Basu SK; Sa B
    J Biomater Sci Polym Ed; 2010; 21(13):1799-814. PubMed ID: 20557689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An investigation into the structure and bioavailability of alpha-tocopherol dispersions in Gelucire 44/14.
    Barker SA; Yap SP; Yuen KH; McCoy CP; Murphy JR; Craig DQ
    J Control Release; 2003 Sep; 91(3):477-88. PubMed ID: 12932724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of polyglycolized glycerides in protection of amorphous form of etoricoxib during compression.
    Shimpi S; Mahadik K; Takada K; Paradkar A
    Chem Pharm Bull (Tokyo); 2007 Oct; 55(10):1448-51. PubMed ID: 17917287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydration of an amphiphilic excipient, Gelucire 44/14.
    Svensson A; Neves C; Cabane B
    Int J Pharm; 2004 Aug; 281(1-2):107-18. PubMed ID: 15288348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro--in vivo evaluation of tableted caseinchitosan microspheres containing diltiazem hydrochloride.
    al-Suwayeh SA; el-Helw AR; al-Mesned AF; Bayomi MA; el-Gorashi AS
    Boll Chim Farm; 2003; 142(1):14-20. PubMed ID: 12680034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liquisolid technique as a new approach to sustain propranolol hydrochloride release from tablet matrices.
    Javadzadeh Y; Musaalrezaei L; Nokhodchi A
    Int J Pharm; 2008 Oct; 362(1-2):102-8. PubMed ID: 18647643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel microparticle drug delivery systems based on chitosan and Eudragit® RSPM to enhance diltiazem hydrochloride release property.
    Cetin EO; Gundogdu E; Kirilmaz L
    Pharm Dev Technol; 2012; 17(6):741-6. PubMed ID: 21563988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of a melt agglomeration process on agglomerates containing solid dispersions.
    Vilhelmsen T; Eliasen H; Schaefer T
    Int J Pharm; 2005 Oct; 303(1-2):132-42. PubMed ID: 16139973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose.
    Yi T; Wan J; Xu H; Yang X
    Eur J Pharm Sci; 2008 Aug; 34(4-5):274-80. PubMed ID: 18541418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Centrifugal air-assisted melt agglomeration for fast-release "granulet" design.
    Wong TW; Musa N
    Int J Pharm; 2012 Jul; 430(1-2):184-96. PubMed ID: 22531845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and characterization of pH-independent sustained release tablet containing solid dispersion granules of a poorly water-soluble drug.
    Tran HT; Park JB; Hong KH; Choi HG; Han HK; Lee J; Oh KT; Lee BJ
    Int J Pharm; 2011 Aug; 415(1-2):83-8. PubMed ID: 21641985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid nanocarriers (GeluPearl) containing amphiphilic lipid Gelucire 50/13 as a novel stabilizer: fabrication, characterization and evaluation for oral drug delivery.
    Date AA; Vador N; Jagtap A; Nagarsenker MS
    Nanotechnology; 2011 Jul; 22(27):275102. PubMed ID: 21606564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poly(ethylene glycol) layered silicate nanocomposites for retarded drug release prepared by hot-melt extrusion.
    Campbell K; Craig DQ; McNally T
    Int J Pharm; 2008 Nov; 363(1-2):126-31. PubMed ID: 18657600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interest of multifunctional lipid excipients: case of Gelucire 44/14.
    Chambin O; Jannin V
    Drug Dev Ind Pharm; 2005 Jul; 31(6):527-34. PubMed ID: 16109625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melt solidification technique: incorporation of higher wax content in ibuprofen beads.
    Kamble R; Maheshwari M; Paradkar A; Kadam S
    AAPS PharmSciTech; 2004 Oct; 5(4):e61. PubMed ID: 15760058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Floating matrix dosage form for dextromethorphan hydrobromide based on gas forming technique: in vitro and in vivo evaluation in healthy volunteers.
    Hu L; Li L; Yang X; Liu W; Yang J; Jia Y; Shang C; Xu H
    Eur J Pharm Sci; 2011 Jan; 42(1-2):99-105. PubMed ID: 21050887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro and in vivo evaluation of multilayered pastilles for chronotherapeutic management of nocturnal asthma.
    Shukla D; Chakraborty S; Mishra B
    Expert Opin Drug Deliv; 2012 Jan; 9(1):9-18. PubMed ID: 22118427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of gelucire content on stability, macrophage interaction and blood circulation of nanoparticles engineered from nanoemulsions.
    Wehrung D; Geldenhuys WJ; Oyewumi MO
    Colloids Surf B Biointerfaces; 2012 Jun; 94():259-65. PubMed ID: 22386863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation and in vitro characterization of diltiazem hydrochloride loaded alginate microspheres.
    Sultana Y; Mall S; Maurya DP; Kumar D; Das M
    Pharm Dev Technol; 2009; 14(3):321-31. PubMed ID: 19235550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.